Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer

NCT00022373 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Head and Neck Cancer
Oral Complications of Radiation Therapy
Radiation Toxicity

Interventions

DRUG: iseganan HCl oral solution
PROCEDURE: management of therapy complications

Sponsor

National Cancer Institute (NCI)